Enlitic, Inc. (ASX:ENL)

Market Cap	6.67M -78.8%
Revenue (ttm)	5.69M +251.9%
Net Income	-20.05M
EPS	-0.03
Shares Out	833.18M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	159,882
Open	0.0080
Previous Close	0.0080
Day's Range	0.0080 - 0.0080
52-Week Range	0.0060 - 0.0450
Beta	-0.53
Analysts	n/a
Price Target	n/a
Earnings Date	May 28, 2026

About Enlitic

Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from med...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2014
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: ENL

Financial Performance

In 2025, Enlitic's revenue was $3.80 million, an increase of 251.87% compared to the previous year's $1.08 million. Losses were -$13.37 million, -12.23% less than in 2024.

Financial numbers in USD